FLML Insider Trading Activity and SEC Form 4 Filings
FLML insider trading summary
No open-market insider purchases or sales of Avadel Pharmaceuticals PLC (FLML) have been reported on SEC Form 4 in the past 12 months.
Latest FLML insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 14, 2018 | Michael F Kanan | See Remarks | Sell | $21K (8,429 @ $2.49) |
| Jun 26, 2018 | Michael F Kanan | See Remarks | Buy | $11K (1,967 @ $5.70) |
| Nov 29, 2016 | Craig R Stapleton | Director | Buy | $109K (10,000 @ $10.85) |
| Nov 28, 2016 | Craig R Stapleton | Director | Buy | $107K (10,000 @ $10.74) |
| Nov 21, 2016 | Michael S Anderson | Chief Executive Officer | Buy | $21K (2,000 @ $10.64) |
| Sep 22, 2016 | Francis Fildes | Director | Sell | $202K (15,000 @ $13.45) |
| Sep 2, 2016 | Michael S Anderson | Chief Executive Officer | Buy | $28K (2,000 @ $14.12) |
| Sep 1, 2016 | Craig R Stapleton | Director | Buy | $135K (10,000 @ $13.52) |
| Aug 26, 2016 | Craig R Stapleton | Director | Buy | $150K (10,878 @ $13.83) |
| Aug 26, 2016 | Craig R Stapleton | Director | Buy | $125K (9,122 @ $13.67) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.